Diclofenac Extended-release Tablets Generics - Manufacturers & Suppliers
Voltaren(US & EU)
| Product/Composition:- | Diclofenac Extended-Release Tablets |
|---|---|
| Strength:- | 100 mg |
| Form:- | Extended-Release Tablets |
| Reference Brands:- | Voltaren(US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Diclofenac ER tablets inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis, which alleviates pain and inflammation. The extended-release formulation provides long-lasting relief, decreases dosing frequency, and improves compliance. Benefits include effective management of chronic pain, arthritis, and inflammatory conditions with sustained, predictable symptom control.
Diclofenac ER (Extended-Release) tablets are approved in the EU and US for managing chronic pain and inflammation. In the EU, brands like Voltaren ER are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments, with generic versions available. Both regions require detailed dossiers for approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate efficient market access for diclofenac ER tablets, ensuring adherence to European and American standards for safe, effective long-term anti-inflammatory therapy.